Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.

Autor: van Rees DJ; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands., Bouti P; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands P.Bouti@sanquin.nl., Klein B; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands., Verkuijlen PJH; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands., van Houdt M; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands., Schornagel K; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands., Tool ATJ; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands., Venet D; Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Bruxelles, Belgium., Sotiriou C; Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Bruxelles, Belgium., El-Abed S; Breast International Group, Brussels, Belgium., Izquierdo M; Novartis Pharma AG, Basel, Switzerland., Guillaume S; Department of Psychiatric Emergency & Acute Care, Lapeyronie Hospital, Montpellier, France., Saura C; SOLTI Innovative Breast Cancer Research, Vall d'Hebron Hospital Universitari, Barcelona, Spain., Di Cosimo S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Huober J; Breast Center, University of Ulm, Ulm, Germany., Roylance R; Department of Oncology, University College London Hospitals NHS Foundation Trust and NIHR University College London Hospitals Biomedical Research Centre, London, UK., Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Kuijpers TW; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.; Department of Pediatric Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., van Bruggen R; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands., van den Berg TK; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Matlung HL; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jun; Vol. 10 (6).

Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al .

Autor: Martinez Sanz P; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands p.martinezsanz@sanquin.nl., van Rees DJ; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Matlung HL; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Tytgat GAM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Franke K; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Dec; Vol. 9 (12).

Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.

Autor: Matlung HL; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Babes L; Immunology Research Group, University of Calgary, Calgary, Alberta, Canada., Zhao XW; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., van Houdt M; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Treffers LW; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., van Rees DJ; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Franke K; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Schornagel K; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Verkuijlen P; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Janssen H; Division of Cell Biology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Halonen P; Division of Molecular Carcinogenesis and the NKI Robotics and Screening Center, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Lieftink C; Division of Molecular Carcinogenesis and the NKI Robotics and Screening Center, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Beijersbergen RL; Division of Molecular Carcinogenesis and the NKI Robotics and Screening Center, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Leusen JHW; Immunotherapy Laboratory, Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Boelens JJ; U-DANCE, Laboratory for Translational Immunology, UMC Utrecht, Utrecht, the Netherlands; Department of Pediatrics, Blood and Marrow Transplantation Program, UMC Utrecht, Utrecht, the Netherlands., Kuhnle I; Department of Pediatrics, University Medicine Göttingen, Göttingen, Germany., van der Werff Ten Bosch J; Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels, Belgium., Seeger K; Department of Pediatric Oncology/Hematology, Otto-Heubner-Center for Pediatric and Adolescent Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany., Rutella S; Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar., Pagliara D; Department of Pediatric Hematology/Oncology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy., Matozaki T; Department of Biochemistry and Molecular Biology, Division of Molecular and Cellular Signaling, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan., Suzuki E; Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan., Menke-van der Houven van Oordt CW; Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands., van Bruggen R; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Roos D; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., van Lier RAW; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Kuijpers TW; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Emma Children's Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands., Kubes P; Immunology Research Group, University of Calgary, Calgary, Alberta, Canada., van den Berg TK; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Department of Molecular Cell Biology and Immunology, VU Medical Center, Amsterdam, the Netherlands. Electronic address: t.k.vandenberg@sanquin.nl.

Publikováno v: Cell reports [Cell Rep] 2018 Jun 26; Vol. 23 (13), pp. 3946-3959.e6.

Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: a role for granule components.

Autor: Gazendam RP; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands r.gazendam@sanquin.nl., van de Geer A; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., van Hamme JL; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., Tool AT; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., van Rees DJ; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., Aarts CE; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., van den Biggelaar M; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., van Alphen F; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., Verkuijlen P; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., Meijer AB; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., Janssen H; The Netherlands Netherlands Cancer Institute, Division of Cell Biology, Amsterdam, The Netherlands., Roos D; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., van den Berg TK; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands., Kuijpers TW; Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Haematologica [Haematologica] 2016 May; Vol. 101 (5), pp. 587-96. Date of Electronic Publication: 2016 Jan 22.